Latest Breaking News On - Licensed subject matter - Page 1 : vimarsana.com

Form 8-K HEAT BIOLOGICS, INC For: Apr 18

Form 8-K HEAT BIOLOGICS, INC For: Apr 18
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyUnited kingdomPine brookState of texasSan antonioUniversity of texasBrent iversonDavid lasseterJeff wolfGeorge georgiouAndrew weber jackSkunkworx bioDavid waldmanBarrettr harveyBrentl iverson

Artelo Biosciences : Annual Transition Report (Form 10-KT)

artl 10kt.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION . | March 21, 2022

United statesUnited kingdomSolana beachSan diego countyLomas santa feTrinity college dublinGood laboratory practiceResearch developmentPfizer incClinical healthTetra bio pharma incDepartment of justiceStony brook university relationshipNational institutes of healthUniversity of western ontarioDrug administration

Form 8-K Moleculin Biotech, Inc For: Dec 20

Form 8-K Moleculin Biotech, Inc For: Dec 20
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCzech republicSao tomeSao tome and principePapua new guineaSaint luciaGuinea bissauCook islandsUnited arab emiratesCosta ricaCabo verdeSierra leoneHarris countyMarshall islandsTrinidad and tobagoState of texas

Form 10-K ARTELO BIOSCIENCES, INC For: Aug 31

Form 10-K ARTELO BIOSCIENCES, INC For: Aug 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan diego countyState of nevadaSolana beachLomas santa fePharmacol physiolTrinity college dublinUs courtGood laboratory practiceResearch developmentUnited states supreme courtTrademark officeNasdaq hearings panel thePfizer incClinical health